COVID 19 vaccine distribution solution to the last mile challenge: Experimental and simulation studies of ultra-low temperature refrigeration system.
CFD, Computational Fluid Dynamic
CFM, Cubic Feet per Minute
COVID 19
FAV, Fresh Air Ventilation
HFC, Hydrofluorocarbons
IWG, Inch Water Gauge
NDIR, Non-Dispersive InfraRed
NIOSH, National Institute for Occupational Safety and Health
ORNL, Oak Ridge National Laboratory
PUR, Polyurethane
Refrigeration
TN, Tennessee
Ultra-low temperature
Vaccine distribution
Vaccine storage
Journal
Revue internationale du froid
ISSN: 0140-7007
Titre abrégé: Int J Refrig
Pays: Netherlands
ID NLM: 101544778
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
received:
14
09
2021
revised:
01
11
2021
accepted:
05
11
2021
pubmed:
16
11
2021
medline:
16
11
2021
entrez:
15
11
2021
Statut:
ppublish
Résumé
Most COVID-19 vaccines require ambient temperature control for transportation and storage. Both Pfizer and Moderna vaccines are based on mRNA and lipid nanoparticles requiring low temperature storage. The Pfizer vaccine requires ultra-low temperature storage (between -80 °C and -60 °C), while the Moderna vaccine requires -30 °C storage. Pfizer has designed a reusable package for transportation and storage that can keep the vaccine at the target temperature for 10 days. However, the last stage of distribution is quite challenging, especially for rural or suburban areas, where local towns, pharmacy chains and hospitals may not have the infrastructure required to store the vaccine. Also, the need for a large amount of ultra-low temperature refrigeration equipment in a short time period creates tremendous pressure on the equipment suppliers. In addition, there is limited data available to address ancillary challenges of the distribution framework for both transportation and storage stages. As such, there is a need for a quick, effective, secure, and safe solution to mitigate the challenges faced by vaccine distribution logistics. The study proposes an effective, secure, and safe ultra-low temperature refrigeration solution to resolve the vaccine distribution last mile challenge. The approach is to utilize commercially available products, such as refrigeration container units, and retrofit them to meet the vaccine storage temperature requirement. Both experimental and simulation studies are conducted to evaluate the technical merits of this solution with the ability to control temperature at -30 °C or -70 °C as part of the last mile supply chain for vaccine candidates.
Identifiants
pubmed: 34776559
doi: 10.1016/j.ijrefrig.2021.11.005
pii: S0140-7007(21)00419-9
pmc: PMC8572735
doi:
Types de publication
Journal Article
Langues
eng
Pagination
313-325Informations de copyright
© 2021 Elsevier Ltd and IIR. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.